Kristopher Jerry, DPM
Foot & Ankle Surgery · Port St Lucie, FLNPI 1063861979
Payments from drug & device makers
Across 114 payments — averaging $183.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$4K
- Arthrex$4K
- Treace Medical Concepts, Inc.$3K
- Stryker$2K
- Triad Life Sciences Inc.$1K
- In2bones USA, LLC$1K
- plus $6K from 29 others
What the payments were for
- Speaking & faculty fees$910%
- Travel & lodging$6,68332%
- Food & beverage$4,97824%
- Education$4,82123%
- Entertainment$1661%
- Other$4,20020%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 2 | $4,200 |
| Arthrex | 3 | $4,156 |
| Treace Medical Concepts, Inc. | 19 | $2,691 |
| Stryker(2 entities) | 12 | $1,575 |
| Triad Life Sciences Inc. | 3 | $1,338 |
| In2bones USA, LLC | 3 | $1,299 |
| Paragon 28, Inc. | 2 | $1,203 |
| Trimed, Inc. | 2 | $686 |
| Southern Edge Orthopaedics, Inc. | 1 | $685 |
| Medartis Inc. | 1 | $509 |
| International Life Sciences | 2 | $488 |
| Kerecis Limited | 6 | $339 |
| Smith+Nephew | 10 | $225 |
| Organogenesis Inc. | 7 | $179 |
| Reprise Biomedical, Inc. | 1 | $175 |
| Integra Lifesciences Corporation | 3 | $165 |
| Medshape, Inc. | 1 | $148 |
| Amgen | 3 | $142 |
| Paratek Pharmaceuticals, Inc. | 8 | $137 |
| GRT US Holding, Inc. | 4 | $96 |
| Nevro Corp. | 5 | $95 |
| Bard Peripheral Vascular, Inc. | 2 | $93 |
| Crossroads Extremity Systems, LLC | 1 | $54 |
| ERMI LLC | 1 | $38 |
| Bioventus LLC | 2 | $37 |
| Biotissue Holdings Inc. | 1 | $32 |
| Abbott | 1 | $21 |
| Medtronic | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $19 |
| Mimedx Group, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Alfasigma USA, Inc. | 1 | $16 |
| DJO, LLC | 1 | $15 |
| KCI USA, Inc. | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$5,497
- Lapiplasty System$2,109
- CoLink$1,299
- Product Portfolio$1,203
- AUGMENT INJECTABLE$598
- APTUS$509
- HOFFMANN$450
- CITREFIX$263
- MIRO3D$175
- DynaNail$148
- Kerecis Omega3 Wound$132
- Kerecis Omega3 Surgibind$132
- Kerecis Omega3 GraftGuide$132
- Kerecis Omega3 SurgiClose$132
- FLEXBAND$120
- TMC NANOPLASTY SYSTEM$120
- KRYSTEXXA$116
- BILAYER WOUND MATRIX (BWM)$115
- INTEGRA WOUND MATRIX (IWM)$115
- AMNIOEXCEL$115
How this compares
$20,938 in reported general payments places this provider in the 85th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 11 | $3,242 |
| CiclopiroxCiclopirox Olamine | 98 | $2,748 |
| Ciclopirox | 22 | $743 |
| Gentamicin Sulfate | 14 | $512 |
| Methylprednisolone | 89 | $483 |
| Cephalexin | 52 | $243 |
| Mupirocin | 34 | $215 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $145 |
| Clindamycin Hcl | 18 | $102 |
| Ibuprofen | 11 | $81 |
| Meloxicam | 16 | $29 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $225 | $3,24211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 850 foot & ankle surgery providers in Florida.
Other foot & ankle surgery in Port St Lucie
- Josh SebagPort St Lucie$291K
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1.1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$938K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$814K
- Riquel GonzalezHialeah$612K
- Mario CalaHialeah$544K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.